BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23327868)

  • 1. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
    Liu Q; Wang S; Xu H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
    Li J; Tu Y; Jiang L; Xu H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    Zhang S; Wang Y; Dai SD; Wang EH
    BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
    Gao Q; Yang S; Kang MQ
    Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer].
    Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New P16 Expression Criteria Predict Lymph Node Metastasis in Patients With Non-small Cell Lung Cancer.
    An HJ; Koh HM; Song DH
    In Vivo; 2019; 33(6):1885-1892. PubMed ID: 31662516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of MIF and CD147 in non-small cell lung cancer].
    Liu Q; Yang H; Zhang SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):85-90. PubMed ID: 20369477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
    Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).
    Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S
    Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
    Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.